Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1817791
Max Phase: Preclinical
Molecular Formula: C14H9F3O
Molecular Weight: 250.22
Molecule Type: Small molecule
Associated Items:
ID: ALA1817791
Max Phase: Preclinical
Molecular Formula: C14H9F3O
Molecular Weight: 250.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Oc1ccc(/C=C/c2cc(F)c(F)c(F)c2)cc1
Standard InChI: InChI=1S/C14H9F3O/c15-12-7-10(8-13(16)14(12)17)2-1-9-3-5-11(18)6-4-9/h1-8,18H/b2-1+
Standard InChI Key: PYEBACISHQWCQY-OWOJBTEDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 250.22 | Molecular Weight (Monoisotopic): 250.0605 | AlogP: 3.98 | #Rotatable Bonds: 2 |
Polar Surface Area: 20.23 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.00 | CX Basic pKa: | CX LogP: 4.44 | CX LogD: 4.43 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.63 | Np Likeness Score: -0.13 |
1. Albert S, Horbach R, Deising HB, Siewert B, Csuk R.. (2011) Synthesis and antimicrobial activity of (E) stilbene derivatives., 19 (17): [PMID:21803587] [10.1016/j.bmc.2011.07.015] |
2. Csuk R, Albert S, Siewert B, Schwarz S.. (2012) Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents., 54 [PMID:22749392] [10.1016/j.ejmech.2012.06.015] |
Source(1):